Adaptive Biotechnologies is harnessing the immune system to unleash its power as a natural diagnostic and therapeutic tool to propel a paradigm shift in medicine.

Jan 6, 2026 · Founded in 2009 by brothers Chad and Harlan Robins, Adaptive develops immune system-related products for diagnosis and monitoring of cancer and other diseases. The company, …

Aug 6, 2025 · Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the …

2 days ago · Get Adaptive Biotechnologies Corp (ADPT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Find the latest Adaptive Biotechnologies Corporation (ADPT) stock quote, history, news and other vital information to help you with your stock trading and investing.

4 days ago · Adaptive Biotechnologies is a clinical-stage biotechnology company that focuses on harnessing the adaptive immune system to transform the diagnosis and treatment of disease.

Get the latest Adaptive Biotechnologies Corp (ADPT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...

1 day ago · On February 6, 2026, TD Cowen upgraded Adaptive Biotechnologies Corporation (NASDAQ:ADPT)’s price target to $21 from $20 while keeping a Buy rating, citing a Q4 beat and an …

In 2009, Harlan Robins made a breakthrough that created a window into the adaptive immune system the world hadn’t thought possible. Together, Harlan and his brother Chad, founded Adaptive to meet …

2 days ago · Key findings for Adaptive Biotechnologies Corporation (NASDAQ: ADPT) Positive Near-Term Sentiment May Erode Mid-Term Weak Bias Within Long-Term Strength Context Support is …